Feasibility study of cytokine removal by hemoadsorption in brain-dead humans

Critical Care Medicine

Volumn 36, Issue 1, 2008, Pages 268-272

  Kellum, John A ^a   Venkataraman, Ramesh ^a   Powner, David ^b   Elder, Michele ^a   Hergenroeder, Georgene ^b   Carter, Melinda ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Blood purification; Brain death; Cytokines; Hemoadsorption; Inflammation mediators; Interleukin 10; Interleukin 6; Organ donation; Organ procurement; Sepsis; Transplantation; Tumor necrosis factor

Indexed keywords

CYTOKINE; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; LIOTHYRONINE; TUMOR NECROSIS FACTOR;

AGED; ARTICLE; BRAIN; FEASIBILITY STUDY; FEMALE; HEMADSORPTION; HUMAN; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 37549000553     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000291646.34815.BB     Document Type: Article

References (31)

1. United Network for Organ Sharing: 1996 Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Washington, DC, US Department of Health and Human Services, 1996
2. Kauffman HM, McBride MA, Rosendale JD, et al: Trends in organ donation, recovery and disposition: UNOS data for 1988 -1996. Transplant Proc 1997; 29:3303-3304
3. Mandal AK, Kalligonis AN, Ratner LE: Expanded criteria donors: Attempts to increase the renal transplant donor pool. Adv Ren Replace Ther 2000; 7:117-130
4. Busson M, Benoit G, N'Doye P, et al: Analysis of cadaver donor criteria on the kidney transplant survival rate in 5,129 transplantations. J Urol 1995; 154:356-360
5. Tullius SG, Nieminen M, Bechstein WO, et al: Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model. Kidney Int 1998; 53:465-472
6. Pratschke J, Wilhelm MJ, Kusaka M, et al: Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999; 67:343-348
7. Powner DJ, Hendrich A, Nyhuis A, et al: Changes in serum catecholamine levels in patients who are brain dead. J Heart Lung Transplant 1992; 11:1046-1053
8. Gramm HJ, Zimmermann J, Meinhold H, et al: Hemodynamic responses to noxious stimuli in brain-dead organ donors. Intensive Care Med 1992; 18:493-495
9. Pratschke J, Wilhelm MJ, Kusaka M, et al: Activation of proinflammatory genes in somatic organs as a consequence of brain death. Transplant Proc 1999; 31:1003-1005
10. Stangl M, Zerkaulen T, Theodorakis J, et al: Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 2001; 33:1284-1285
11. Takada M, Nadeau KC, Hancock WW, et al: Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65:1533-1542
12. Lopau K, Mark J, Schramm L, et al: Hormonal changes in brain death and immune activation in the donor. Transpl Int 2000; 13(Suppl 1):S282-S285
13. Wilhelm MJ, Pratschke J, Beato F, et al: Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000; 102:2426-2433
14. Plenz G, Eschert H, Erren M, et al: The interleukin-6/interleukin-6- receptor system is activated in donor hearts. J Am Coll Cardiol 2002; 39:1508-1512
15. Birks EJ, Burton PB, Owen V, et al: Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 2000; 102:352-358
16. Deng MC, Erren M, Kammerling L, et al: The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 1995; 60:1118-1124
17. Kirklin JK, McGiffin DC: Control of the inflammatory response in extended myocardial preservation of the donor heart. Ann Thorac Surg 1999; 68:1978-1982
18. Birks EJ, Owen VJ, Burton PB, et al: Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 2000; 102:326-331
19. Pratschke J, Wilhelm MJ, Kusaka M, et al: Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000; 232: 263-271
20. Novitzky D, Cooper DK, Reichart B: The value of hormonal therapy in improving organ viability in the transplant donor. Transplant Proc 1987; 19:2037-2038
21. Novitzky D, Cooper DK, Reichart B: Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43:852-854
22. Novitzky D, Cooper DK, Chaffin JS, et al: Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990; 49:311-316
23. Pennefather SH, Bullock RE, Mantle D, et al: Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995; 59:58-62
24. Venkataraman R, Song M, Lynas R, et al: Hemoadsorption to improve organ recovery from brain-dead organ donors: A novel therapy for a novel indication? Blood Purif 2004; 22:143-149
25. Song M, Winchester J, Albright RL, et al: Cytokine removal with a novel adsorbent polymer. Blood Purif 2004; 22:428-434
26. Kellum JA, Song M, Venkataraman R: Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-κB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004; 32:801-805
27. Cecka JM: Outcome statistics of renal transplants with an emphasis on long-term survival. Clin Transplant 1994; 8:324-327
28. Terasaki PI, Cecka JM, Gjertson DW, et al: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333:333-336
29. Cecka M: Clinical outcome of renal transplantation: Factors influencing patient and graft survival. Surg Clin North Am 1998; 78:133-148
30. Hariharan S, Johnson CP, Bresnahan BA, et al: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342:605-612
31. Bartlett RH: Vitalin: The rationale for a hypothetical hormone. J Am Coll Surg 2004; 199:286-292